"[O]ur study, which has the largest cohort to date, did not show an increased rate of VTEs in patients with DM on IVIG. Therefore, it is safe to start patients on this medicine as it is one of our ...
Jeffrey V. Ravetch (left) and Andrew T. Jones (right) showed that the anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback